Evidence map›Paper›PMID 31659586›Full record

ArticleInflammation2020

Leonurine Hydrochloride Suppresses Inflammatory Responses and Ameliorates Cartilage Degradation in Osteoarthritis via NF-κB Signaling Pathway.

Cheng Chen, Zhenglin Zhu, Ning Hu, Xi Liang, Wei Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Acacetin Suppresses IL-1BioMed research international · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Cheng ChenDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Zhenglin ZhuDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Ning HuDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Xi LiangDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Wei HuangDepartment of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. huangwei68@263.net.
Chongqing Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

National Natural Science Foundation of China 81572142
6 · The paper itself

Abstract

Leonurine hydrochloride (LH) has been reported to exhibit a number of biological properties such as suppression of inflammation. This study aimed to examine whether the progression of osteoarthritis (OA) could be delayed by the administration of LH in an OA model. Rat chondrocytes were treated with LH under the condition of TNF-α-induced inflammation. After that, real-time PCR and Western blotting were conducted to evaluate relative gene/protein expression levels. For the in vivo study, rats were randomly allocated to a control group (anterior cruciate ligament transection (ACLT) surgery, treatment with saline) and LH group (ACLT surgery, treatment with LH). Articular cartilage degeneration was assessed by histological evaluation. It was found that LH significantly suppressed the expression of MMP-1, MMP-3, MMP-13, IL-6, and ADAMTS-5 in cells via the NF-κB signaling pathway. In addition, it is revealed that intra-articular injection of LH significantly ameliorated cartilage degeneration in a rat OA model. Taken together, these results indicate that LH attenuates progression of OA by inhibition of inflammation via the NF-κB signaling pathway and represents a potential preventive therapy for OA.

Indexed as

ADAMTS5 ProteinAnimalsAnterior Cruciate LigamentAnti-Inflammatory AgentsCartilage, ArticularCartilage DiseasesCell LineChondrocytesGallic AcidInflammationInterleukin-6MaleMatrix Metalloproteinase 1Matrix Metalloproteinase 13Matrix Metalloproteinase 3NF-kappa BADAMTS5 ProteinAdamts5 protein, ratAnti-Inflammatory AgentsGallic AcidIl6 protein, ratInterleukin-6leonurineMatrix Metalloproteinase 1Matrix Metalloproteinase 13Matrix Metalloproteinase 3NF-kappa Banti-inflammationcartilage protectionnatural productpharmacological activity

Identifiers

PMID31659586
OpenAlexW2982631000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.